跳至主要内容
临床试验/NCT02758041
NCT02758041已完成不适用

A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris

Sebacia, Inc.6 个研究点 分布在 2 个国家目标入组 85 人开始时间: 2016年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
85
试验地点
6
主要终点
Percent reduction in lesion count from baseline

研究概览

简要总结

This study is proposed to evaluate Sebacia Microparticle treatment in patients with facial inflammatory acne vulgaris.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 45 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, 16-45 years of age.
  • Moderate to moderately-severe facial inflammatory acne vulgaris
  • Fitzpatrick skin phototype I-III

排除标准

  • Pregnant, lactating, nursing or planning to become pregnant
  • Tattoo in the treatment area
  • Active skin disease, excessive scarring or excess facial hair in the treatment area
  • Certain current or recent acne treatments
  • Recent light treatments including Intense Pulsed Light or other lasers, microdermabrasion or chemical peels in the treatment area
  • Contraindicated for laser treatment, or is unable or unwilling to avoid excessive sun exposure or tanning bed use
  • Known allergy to gold

结局指标

主要结局

Percent reduction in lesion count from baseline

时间窗: Baseline, Week 12, Week 24, Week 36

次要结局

  • Improvement in Investigator Global Acne Score(Baseline, Week 12, Week 24, Week 36)

研究者

发起方
Sebacia, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验